Synapsoft logo
AI Insights from Disclosures
Searching...
VIVOZON PHARMACEUTICAL CO., LTD. 082800
Searching...

Company Summary

Quarterly Performance Revenue Operating Margin

Market Sentiment

※ Click the graph to view AI analysis information for that month.
Revenue
Consolidated
Separate
Operating Income
Consolidated
Separate
Net Income
Consolidated
Separate

Financials

Excel

No financial data is available for this period.
~
Quarterly
Annual
No data is available for this period.

*Values beyond the fourth decimal place of the unit are displayed as '0/-0'

Financial Indicator Forecast

※ These forecasts are simple AI estimates based on historical data and may differ from actual results.

Company Overview

as of June 2026
VIVOZON PHARMACEUTICAL CO., LTD. engages in the manufacture and sale of finished pharmaceutical products and is committed to the research and development of innovative new drugs. Its main products include self-manufactured prescription drugs such as cardiovascular drugs, topical skin preparations, antipyretic analgesic anti-inflammatory drugs, and diabetes treatments, as well as its independently developed over-the-counter drugs Lalaola and Inipoten, and Livertine, an adjuvant treatment for liver disease.
Representative Director Jang Buhwan
Founded August 22, 2002
Corporation Type KOSDAQ
Industry Classification Manufacture of medicaments
Corporate number 13581-0085019
Business number 124-81-99564
Phone Number 02-3434-7600
Fax Number 031-210-7905
Company Address 34-40 Jeyakgongdan 2-gil, Hyangnam-eup, Manse-gu, Hwaseong-si, Gyeonggi-do
Products & Services

Financial Health

Executives

Employees

Shareholders

Industry revenue

Disclosures

Comments

0 / 255

AI Assistant